TTUHSC Research

news & announcements...

WORKSHOPS

 

 

 
 
Dr. Xinli Liu Dr. Ruiwen Zhang Dr. Stephanie Filleur Dr. Jannette Dufour Dr. Kendra Rumbaugh Dr. Quentin Smith Dr. Ruth Perez Dr. Sharma S. Prabhakar Dr. Susan E. Bergeson Dr. Afzal A. Siddiqui Dr. Luis G. Cuello Dr. Guillermo Altenberg
If Your Work Involves Use or Administration of Scheduled Drugs -
ENFORCEMENT OF DEA Policies as Required by Law 

Preparing an NIH Progress Report for a Continuing (Non-competitive) Grant
NEW NIH PROGRESS REPORT

Facilitation of Integration of New Research Volunteers

OP 70.29 for Postdoctoral Appointment and Service
and New Draft Letter of Appointment

*** FACULTY COLLABORATION SEARCH TOOL***
Search by Topic or Research Expert


Dr. Vardan T. Karamyan Receives Two Years Funding from the
American Heart Association to Investigate the Hypothesized Role of
Peptidase Neurolysin in Pathogenesis of Stroke



Dr. Luis G. Cuello Receives Three Years Additional Funding for Research Grant from the Welch Foundation (click here for more info)

 



TTUHSC Receives National Grant
Professor Afzal A. Siddiqui Receives Grant from the Bill & Melinda Gates Foundation (click here for more info)


 New NIH Award to Dr. Michaela Jansen

Dr. Jansen's laboratory has a long-standing interest in studying pentameric ligand-gated ion channels. These receptors are targeted by a multitude of clinically used drugs that include antidepressants, antiepileptics, antiemetics, antipsychotics, anesthetics, muscle relaxants, spasmolytics, tranquillizers, and drugs for the treatment of substance abuse. They also represent novel therapeutic targets to treat inflammatory diseases like atherosclerosis, Alzheimer's, diabetes, inflammatory bowel disease, and sepsis.  She recently received an R01 award from the National Institute of Neurological Disorders and Stroke to investigate the structure and function of the so-far neglected intracellular domain with the goal to evaluate this domain as a new drug target that can then be utilized to design innovative therapeutic drugs with improved selectivity.

 The Research Department is the primary resource and catalyst for advancing research at the Texas Tech University Health Sciences Center. Our mission is to promote and support research by providing high quality service to investigators, foster new research initiatives, promote the prevention of disease and the treatment of illness, motivate and educate future leaders in health sciences, and serve as an advocate for the value of research in an educational setting.

We provide leadership, direction, and management of research administration, infrastructure and services, and oversee the operations of the following areas: Office of Research, Research Integrity Office (RIO), Laboratory Animal Services Center (LARC) and the Office of Sponsored Programs (OSP).

©